J. Goldman & CO LP Eli Lilly & CO Call Options Transaction History

J. Goldman & CO LP

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 14, 2024	SELL	$525.19 - $619.13 $1.79 Million - $2.11 Million	-3,400 Reduced 12.93%	22,900 $13.3 Million
Q3 2023 Nov 14, 2023	BUY	$434.7 - $599.3 $11.4 Million - $15.8 Million	26,300 New	26,300 $14.1 Million
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $83,619 - $98,181	300 New	300 $97,000

4,007

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $749B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

Stay updated on J. Goldman & CO LP with notifications on news.